Armed oncolytic adenovirus can overcome critical obstacles in adoptive T-cell therapy of solid tumors

被引:0
|
作者
Hemminki, Akseli [1 ,2 ,3 ]
Siurala, Mikko [1 ,2 ,3 ]
Tahtinen, Siri
Jokimaki, Riikka
Bramante, Simona
Parviainen, Suvi
机构
[1] Univ Helsinki, Haartman Inst, Dept Pathol, Canc Gene Therapy Grp, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Transplantat Lab, FIN-00014 Helsinki, Finland
[3] TILT Biotherapeut Ltd, Helsinki, Finland
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
INV085
引用
收藏
页码:A20 / A20
页数:1
相关论文
共 50 条
  • [21] Clinical application of adoptive T cell therapy in solid tumors
    Zang, Yi-Wen
    Gu, Xiao-Dong
    Xiang, Jian-Bin
    Chen, Zong-You
    MEDICAL SCIENCE MONITOR, 2014, 20 : 953 - 959
  • [22] Adoptive T-cell therapy
    Lokhorst, HM
    Liebowitz, D
    SEMINARS IN HEMATOLOGY, 1999, 36 (01) : 26 - 29
  • [23] Aging impairs CD8 T cell responses in adoptive T-cell therapy against solid tumors
    Kadyrzhanova, Gulfiya
    Tamai, Miho
    Sarkar, Shukla
    Kalra, Rajkumar Singh
    Ishikawa, Hiroki
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [24] CAR T-cell therapy of solid tumors
    Yong, Carmen S. M.
    Dardalhon, Valerie
    Devaud, Christel
    Taylor, Naomi
    Darcy, Phillip K.
    Kershaw, Michael H.
    IMMUNOLOGY AND CELL BIOLOGY, 2017, 95 (04): : 356 - 363
  • [25] CAR T-cell Therapy for Solid Tumors?
    Harper, Kristin
    CANCER DISCOVERY, 2018, 8 (11) : 1341 - 1341
  • [26] Exploring Novel Viro-Immunotherapies Using "Armed" Oncolytic Adenoviruses and Adoptive T-Cell Therapy to Target Pancreatic Ductal Adenocarcinoma
    Roach, Brett L.
    Yamamoto, Masato
    MOLECULAR THERAPY, 2022, 30 (04) : 322 - 322
  • [27] Exploring Novel Viro-Immunotherapies Using "Armed" Oncolytic Adenoviruses and Adoptive T-cell Therapy to Target Pancreatic Ductal Adenocarcinoma
    Roach, Brett L.
    Yamamoto, Masato
    MOLECULAR THERAPY, 2023, 31 (04) : 298 - 299
  • [28] T-cell adoptive therapy of tumors: Mechanisms of improved therapeutic performance
    Cohen, PA
    Peng, LM
    Kjaergaard, J
    Plautz, GE
    Finke, JH
    Koski, GK
    Czerniecki, BJ
    Shu, SY
    CRITICAL REVIEWS IN IMMUNOLOGY, 2001, 21 (1-3) : 215 - 248
  • [29] Feasibility of a phase I personalized adoptive T-cell therapy in patients with relapsed/refractory solid tumors
    Tsimberidou, Apostolia
    Mohamed, Ali
    Eck, Stephen
    Singh, Harpreet
    Hwu, Patrick
    Yee, Cassian
    Andersson, Borje
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [30] Oncolytic virus and CAR-T cell therapy in solid tumors
    Ponterio, Eleonora
    Haas, Tobias Longin
    De Maria, Ruggero
    FRONTIERS IN IMMUNOLOGY, 2024, 15